[{"id":"ff68ee87-5cf9-4a0a-ac3b-71e15898e51d","acronym":"","url":"https://clinicaltrials.gov/study/NCT03692663","created_at":"2022-08-01T19:03:33.391Z","updated_at":"2024-07-02T16:36:06.382Z","phase":"Phase 1","brief_title":"Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer","source_id_and_acronym":"NCT03692663","lead_sponsor":"Allife Medical Science and Technology Co., Ltd.","biomarkers":" NCAM1","pipe":" | ","alterations":" FOLH1 expression","tags":["NCAM1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FOLH1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • ALF501"],"overall_status":"Recruiting","enrollment":" Enrollment 9","initiation":"Initiation: 12/01/2018","start_date":" 12/01/2018","primary_txt":" Primary completion: 06/01/2023","primary_completion_date":" 06/01/2023","study_txt":" Completion: 06/01/2024","study_completion_date":" 06/01/2024","last_update_posted":"2022-08-01"}]